Related Posts Plugin for WordPress, Blogger...

Med Ed Scoopit

Friday, May 10, 2013

Bacterial Infection in Mosquitoes Renders Them Immune to Malaria Parasites Strategy - Holds Promise for Malaria Control Efforts



Bacterial Infection in Mosquitoes Renders Them Immune to Malaria Parasites Strategy - Holds Promise for Malaria Control Efforts

WHAT:
Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health,  have established an inheritable bacterial infection in malaria-transmitting Anopheles mosquitoes that renders them immune to malaria parasites. 
Specifically, the scientists infected the mosquitoes with Wolbachia, a bacterium common among insects that previously has been shown to prevent malaria-inducing Plasmodium parasites from developing inAnopheles mosquitoes. Before now, researchers had been unable to create mosquitoes with a stableWolbachia infection that passed consistently from mother to offspring.
In this study, led by Zhiyong Xi, Ph.D., at Michigan State University, the researchers focused onAnopheles stephensi mosquitoes, the primary malaria carrier in the Middle East and South Asia. The scientists injected Wolbachia into male and female embryos of A. stephensi and, once they matured, mated the adult females with uninfected male mosquitoes.
A stable Wolbachia infection was maintained for 34 generations of mosquitoes, at which time the study ended. The researchers also introduced Wolbachia infection into uninfected adult mosquitoes in a series of experiments in which infected female mosquitoes comprised 5 percent, 10 percent or 20 percent of the mosquito population.
 In all three experiments, 100 percent of the mosquitoes were infected within eight generations, supporting the potential of Wolbachia-infected mosquitoes as a malaria control strategy. Similar approaches have been used successfully to control dengue, another mosquito-borne disease, in certain settings.
In their examination of how Wolbachia affects Plasmodium parasites, the researchers found that the bacterium kills the parasites both in the mosquito midgut, where the parasites mature, and in the salivary glands, from which the parasites are transmitted to humans via mosquito bites. 
The scientists hypothesize that Wolbachia infection causes the formation of unstable compounds known as reactive oxygen species (ROS), which inhibit the development of the parasites. Future studies might examine whether Plasmodiumcan become resistant to ROS and explore ways to integrate Wolbachia-infected mosquitoes with existing malaria control strategies, the researchers write.
ARTICLE:
Bian G et al. Wolbachia invades Anopheles stephensi populations and induces refractoriness to Plasmodium infection. Science. DOI:
WHO:
Adriana Costero-Saint Denis, Ph.D., vector biology program officer in NIAID’s Parasitology and International Programs Branch, is available to discuss the findings.
CONTACT:
To schedule interviews, please contact Nalini Padmanabhan, (301) 402-1663, niaidnews@niaid.nih.gov.
NIH...Turning Discovery Into Health ®  
Link to article:

Saturday, April 20, 2013

Organization for Women in Science for the Developing World Invites Nominations for 2014 Elsevier Foundation Awards

Posted on April 13, 2013
Deadline: September 15, 2013


Organization for Women in Science for the Developing World Invites Nominations for 2014 Elsevier Foundation Awards

The Organization for Women in Science for the Developing World, in partnership with the Elsevier Foundation and TWAS, is accepting nominations for the 2014 Elseveier Foundation Awards to support research, build capacity, and inspire a new generation of women scientists in the developing world. The annual awards program recognizes talented early career women scientists from Africa, the Middle East, Asia, Latin America, and the Caribbean. This year, the program's focus is chemistry.

Five scientists will receive a cash prize of $5,000 in addition to a year's access to Science Direct, a database of scientific journal articles and books, as well as all-expenses paid attendance at the annual American Association for the Advancement of Science conference in February 2014.

Nominations will be accepted from early career scientists (within ten years of graduating with a PhD) from the eighty-one countries TWAS defines as scientifically lagging.

See the Organization for Women in Science for the Developing World Web site for eligibility and nomination guidelines.

Primary Subject: Science/Technology
Secondary Subject(s): Women 

Sunday, March 17, 2013

Call for Nominations: Prince Mahidol Award 2013


Call for Nominations: Prince Mahidol Award 2013.  On of the two decades of the Award and 122th anniversary of the Birthday of His Royal Highness Prince Mahidol of Songkla which is closely approaching  in 2014, we would like to invite you to nominate individual (s) or institution(s) for their outstanding performance and/or research that contributes directly to the betterment of society.

Two Prince Mahidol Awards will be conferred on an annual basis, one in medicine and one in public health, each prize increase from $50,000 to $100,000 plus a medal and a certificate.

The Prince Mahidol Award Ceremony will be held in Bangkok on the last week of January of the following year and presided over by His Majesty the King of Thailand who is the youngest son of Prince Mahidol and has graciously granted Royal Patronage to the Foundation.

Submission Methods

1. All nominations can be submitted by three methods:

(1) PREFERRED METHOD: Submit online via the Nomination Submission Online. Nominators are strongly encouraged to use this method.

(2) E-mail the nomination form and all supporting materials as attached files to  supat.van@mahidol.ac.th

(3) Regular mail delivery. Please send the complete nomination and all supporting materials to:
Secretary-General
Prince Mahidol Award Foundation
2nd Floor, Mahidol-Bumpen Building,
Siriraj Hospital, Mahidol University,
2 Prannok Road, Bangkoknoi, Bangkok 10700 THAILAND

Nominations must be received no later than midnight local time on May 31, 2013.

 Nominations that arrive after the deadline will be held over to the following year for consideration.  Nominations that did not result in an award can be resubmitted or updated in subsequent years.

Self-nominations are NOT ACCEPTED.

For more information about the submission process, please contact Prof. Supat Vanichakarn,M.D., secretary-general at Supat.van@mahidol.ac.th or pmaf@mahidol.ac.th

Thursday, March 7, 2013

MRSA Data Show Increased Risk for Children During Summer


MRSA Data Show Increased Risk for Children During Summer

Steven Fox
Mar 05, 2013

Recent data on methicillin-resistant Staphylococcus aureus (MRSA) demonstrate seasonal variations that may put children at increased risk during the summer and seniors at greater risk during the winter, according to a study published online February 28 in the American Journal of Epidemiology.
"Community-associated MRSA (CA-MRSA) is a growing problem in US hospitals, which are already dealing with high levels of hospital-associated MRSA (HA-MRSA), but little is known about how patient age and seasonal differences in the incidence of these 2 forms of MRSA affect the epidemic," note Eili Y. Klein, PhD, from the Department of Ecology and Evolutionary Biology, Princeton University, New Jersey, and colleagues.
Citing earlier research, the authors note that MRSA-related hospitalizations doubled in the United States between 1999 and 2005, but that this increase was fueled primarily by MRSA acquired in community settings, rather than in hospitals or other healthcare settings, as had been the case before that time.
Aiming to find out more about the magnitude and trends in annual S aureus and MRSA hospitalizations, Dr. Klein and colleagues assessed 2005 to 2009 national data on hospitalizations and antibiotic resistance.
They say that although they saw no statistically significant increase in rates of hospitalization during the period studied, the total number of infections did increase. "In 2009, there were an estimated 463,017 (95% confidence interval: 441,595, 484,439) MRSA-related hospitalizations at a rate of 11.74 (95% confidence interval: 11.20, 12.28) per 1,000 hospitalizations," they write.
The investigators also note that there were significant differences in infection type by age, with HA-MRSA-related hospitalizations being more common in older people and CA-MRSA more common in youngsters.
In fact, they say, during 2008, nearly three quarters (74%) of individuals younger than 20 years who developed a MRSA infection acquired the infection in a community setting, rather than in a hospital.
In addition, the authors say they saw significant seasonal variations in the incidence of MRSA, especially among children, with CA-MRSA peaking during the late summer and HA-MRSA peaking during the winter. They hypothesize that such variations may be largely a result of seasonal variations in how antibiotics are prescribed.
"Further validation of seasonal patterns of infection and resistance is warranted because understanding seasonal patterns can improve patient care by informing more prudent drug prescription practices, diagnoses, infection control programs, and seasonally appropriate treatment guidelines," the authors conclude.
This work was supported by the Health Grand Challenges Program at Princeton University. Additional support was provided by the Extending the Cure 505 Project, which is supported by the Pioneer Portfolio at the Robert Wood Johnson Foundation. The authors have disclosed no relevant financial relationships.
Am J Epidemiol. Published online February 28, 2013. Abstract
 

Sunday, February 24, 2013

New Adult Immunization Schedule: A Quick Overview


New Adult Immunization Schedule: A Quick Overview
Sandra Adamson Fryhofer, MD
Jan 29, 2013
Hello. I'm Dr. Sandra Fryhofer. Welcome to Medicine Matters. 
The topic: immunization 2013 -- a review of key changes in the Advisory Committee on Immunization Practices' (ACIP's) new adult immunization schedule published in Annals of Internal Medicine.[1] Here is why it matters.
Each year, as many as 50,000 adult Americans die of vaccine-preventable diseases. That's why adult immunizations are important and must be timely. Of note, many of the changes in the new schedule are off-label uses and thus extend beyond US Food and Drug Administration (FDA)-approved licensing parameters. Here is what's new.
Tdap
The policy change in Tdap, the tetanus, diphtheria, acellular pertussis vaccine, comes on the heels of pertussis outbreaks across the United States. The new recommendation is to vaccinate pregnant women in each and every pregnancy in the third trimester, preferably between 27 and 36 weeks. This includes pregnant women who have been vaccinated previously. Tdap is FDA approved for adults as single use only, so repeat maternal vaccination is an off-label use. Tdap booster is recommended universally for all adults, including those aged 65 years and older.
Pneumococcal Vaccine
There is a change in pneumococcal vaccination strategies for immunocompromised adults. ACIP recommends that pneumococcal conjugate vaccine (PCV) 13 (Prevnar 13), a new PCV vaccine, be given to all immunocompromised adults ages 19 years and older. It should be given in addition to, not instead of, pneumococcal polysaccharide vaccine (PPSV) 23 (Pneumovax). Patients include those with functional or anatomic asplenia, HIV infection, cancer, advanced kidney disease, or other immunocompromising conditions. Timing and order of the 2 vaccinations are important, so check the new adult schedule for the details. This recommendation also deviates from FDA licensing. When ACIP made this recommendation, Prevnar was FDA approved for adults age 50 and older but not for those ages 19-49.
Influenza
Influenza vaccination is recommended for everyone over 6 months old. That still stands, but there has been a name change. Instead of TIV, which stands for trivalent inactivated influenza vaccine, the new name is IIV -- inactivated influenza vaccine. Also, starting next year, many manufacturers will transition from a trivalent formulation that covers 2 strains of influenza A and 1 strain of influenza B to a quadrivalent formulation that doubles the coverage for these strains. For specific adult vaccine information at your fingertips, download the ACP Immunization Advisor from the Website or asmobile app.
For Medicine Matters, I'm Dr. Sandra Fryhofer.
References
  1. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2013. Ann Intern Med. 2013;158:191-199.

Medscape Internal Medicine © 2013  WebMD, LLC 
Cite this article: New Adult Immunization Schedule: A Quick Overview. Medscape. Jan 29, 2013.

Wednesday, February 20, 2013

Sigma Theta Tau International Global Research Grant


Posted: 19 Feb 2013 08:46 AM PST





Sigma Theta Tau International Global Research Grant

Application deadline is 1 May 2013.

​The Honor Society of Nursing, Sigma Theta Tau International (STTI) has established the Sigma Theta Tau International Global Research Grant in honor of Patricia E. Thompson, EdD, RN, FAAN, CEO of the honor society. Annual funding of US $12,000 (maximum) is provided by the Foundation’s Patricia E. Thompson Giving Circle donors.

Application deadline is 1 May 2013, and funding date is 1 November 2013.
To be eligible for grant consideration, projects should focus on a global response to health disparities. Principal investigators should be registered nurses (or country equivalent) with current licenses and at least a master’s in nursing (or country equivalent).

A completed research application package and signed research agreement, together with appropriate additional documentation and letters of support, must be submitted by the deadline (no extensions). Also, applicants must be ready to implement the research project when funding is received, including proof of Institutional Review Board approval (or country equivalent). The project must be completed within 18 months of funding.

Grant recipients MUST:
Submit a final report to STTI as well as a completed abstract to STTI’s Virginia Henderson International Nursing Library.

Disseminate research findings through publication, podium presentation, or poster presentation at STTI’s research congress, biennial convention, and/or a regional meeting.
Be present at the STTI convention to accept the award.

How to apply
All applications must be submitted via the online submission system, http://stti.grant.confex.com/stti_grant/global13/cfp.cgi

For additional information about this and other grant opportunities available from the Foundation, contact Tonna Thomas at tonna@stti.iupui.edu or online at http://www.nursingsociety.org/Research/Grants.